JP2024539499A - 神経修復を促進するためのイソロイホリン及びその誘導体の用途 - Google Patents

神経修復を促進するためのイソロイホリン及びその誘導体の用途 Download PDF

Info

Publication number
JP2024539499A
JP2024539499A JP2024547815A JP2024547815A JP2024539499A JP 2024539499 A JP2024539499 A JP 2024539499A JP 2024547815 A JP2024547815 A JP 2024547815A JP 2024547815 A JP2024547815 A JP 2024547815A JP 2024539499 A JP2024539499 A JP 2024539499A
Authority
JP
Japan
Prior art keywords
isorhoifolin
nerve
derivatives
isoleufolin
neurons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547815A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539499A5 (cg-RX-API-DMAC7.html
Inventor
陳令儀
陳裕仁
廖▲ぶん▼玲
王翊
李育棠
呂亭萱
李家維
陳方儀
焦伝金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2024539499A publication Critical patent/JP2024539499A/ja
Publication of JP2024539499A5 publication Critical patent/JP2024539499A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2024547815A 2021-10-25 2022-10-25 神経修復を促進するためのイソロイホリン及びその誘導体の用途 Pending JP2024539499A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163271411P 2021-10-25 2021-10-25
US63/271,411 2021-10-25
PCT/CN2022/127372 WO2023072069A1 (zh) 2021-10-25 2022-10-25 异野漆树苷及其衍生物用于促进神经修复的用途

Publications (2)

Publication Number Publication Date
JP2024539499A true JP2024539499A (ja) 2024-10-28
JP2024539499A5 JP2024539499A5 (cg-RX-API-DMAC7.html) 2025-10-28

Family

ID=86159046

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024547815A Pending JP2024539499A (ja) 2021-10-25 2022-10-25 神経修復を促進するためのイソロイホリン及びその誘導体の用途
JP2024547816A Pending JP2024541121A (ja) 2021-10-25 2022-10-25 イソプロピル-d-グルコピラノシド誘導体、製造方法及びその用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024547816A Pending JP2024541121A (ja) 2021-10-25 2022-10-25 イソプロピル-d-グルコピラノシド誘導体、製造方法及びその用途

Country Status (7)

Country Link
US (2) US20240415859A1 (cg-RX-API-DMAC7.html)
EP (2) EP4424695A4 (cg-RX-API-DMAC7.html)
JP (2) JP2024539499A (cg-RX-API-DMAC7.html)
KR (2) KR20240090982A (cg-RX-API-DMAC7.html)
CN (2) CN118215669A (cg-RX-API-DMAC7.html)
TW (1) TWI898161B (cg-RX-API-DMAC7.html)
WO (2) WO2023072085A1 (cg-RX-API-DMAC7.html)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045072A (zh) * 2007-05-08 2007-10-03 胡军 山香圆叶提取物及其医药用途
CN102617659A (zh) * 2012-03-09 2012-08-01 中国烟草总公司郑州烟草研究院 α-紫罗兰醇葡糖苷的合成方法及其在卷烟中的加香应用
CN102617658B (zh) * 2012-03-09 2014-08-20 中国烟草总公司郑州烟草研究院 β-紫罗兰醇-β-D-葡糖苷的制备方法及其在烟草加香中的应用
CN106167508A (zh) * 2016-07-13 2016-11-30 上海应用技术学院 一种具有紫罗兰香味的葡萄糖苷化合物及其制备方法

Also Published As

Publication number Publication date
JP2024541121A (ja) 2024-11-06
US20240415859A1 (en) 2024-12-19
TW202320806A (zh) 2023-06-01
CN118215669A (zh) 2024-06-18
KR20240090983A (ko) 2024-06-21
KR20240090982A (ko) 2024-06-21
EP4424694A1 (en) 2024-09-04
TWI898161B (zh) 2025-09-21
WO2023072069A1 (zh) 2023-05-04
US20250255893A1 (en) 2025-08-14
CN118139869A (zh) 2024-06-04
TW202317142A (zh) 2023-05-01
EP4424695A4 (en) 2025-10-22
EP4424695A1 (en) 2024-09-04
WO2023072085A1 (zh) 2023-05-04
EP4424694A4 (en) 2026-03-11

Similar Documents

Publication Publication Date Title
CN112646774B (zh) 用线粒体特化细胞治疗神经退行性疾病的医药组合物
TR201816335T4 (tr) Alzheimer hastalığının tespitine yönelik optik yöntem.
Tao et al. Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye
Liu et al. A novel rat model of ocular hypertension by a single intracameral injection of cross‐linked hyaluronic acid hydrogel (Healaflow®)
TWI898161B (zh) 異野漆樹苷及其衍生物用於促進神經修復的用途
Yoo et al. Corneal neuro-regenerative effect of transcutaneous electrical stimulation in rabbit lamellar keratectomy model
CN116008558B (zh) 细胞外基质弹性蛋白降解物在制备诊断或延缓神经退行性疾病的产品中的应用
JP2024539499A5 (cg-RX-API-DMAC7.html)
Wang et al. Olfactory mucosa mesenchymal stem cell‐derived exosomes protect against neuroinflammation after subarachnoid hemorrhage by activating mitophagy
Du et al. Visual recovery following optic nerve crush in male and female wild-type and TRIF-deficient mice
Tanriverdi et al. Understanding of dry eye in subarachnoid hemorrhage: an experimental study on the role of facial nerve ischemia
KR20140125659A (ko) 좌뇌 내측 전전두엽의 광유전적 자극을 통한 우울증 치료방법
Shoae-Hassani et al. Encapsulated mesenchymal stem cell-derived exosomes promote optic nerve regeneration and functional recovery in a mouse model of optic nerve crush injury
RU2279886C2 (ru) Способ улучшения функциональной активности сетчатки при ее патологии различного генеза
Cai et al. Pathologic changes in chronic intraorbital optic nerve damage in rabbits
TWI823110B (zh) 天南星科萃取物用於促進神經修復的用途
JP2024541121A5 (cg-RX-API-DMAC7.html)
CN110279685A (zh) L-丝氨酸在预防或治疗高原颅脑损伤中的应用
CN111617234B (zh) 外源性重组蛋白Reelin在制备治疗脑出血药物中的应用
Hwang et al. Stem cells ameliorate neurotrauma-induced visual disturbances and retinopathy via broad normalization of the β-catenin-related signaling pathway
KR102477030B1 (ko) 인간 전분화능 줄기세포 유래 신경전구세포를 유효성분으로 포함하는 혈관성 치매 예방 또는 치료용 약학 조성물
Heng Vision Restoration in a Newly Characterized Porcine Model of Traumatic Optic Neuropathy
Fan et al. Maternal Exposure to Sevoflurane Disrupts Oligodendrocyte Myelination of the Postnatal Hippocampus and Induces Cognitive and Motor Impairments in Offspring
Luzadre Neurogenesis and Functional Recovery of Murine Retinal Ganglion Cells After Glaucoma Induction Following Treatment With PNU-282987
Hesse 11 Surgical Treatments

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20250825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20250825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251020

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251017

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251118

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20260422

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20260422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260807